SHE · Healthcare

Yantai Zhenghai Bio-Tech Co Ltd (300653)

Biotechnology

Yantai Zhenghai Bio-Tech Co Ltd (300653) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $3.48B, P/E ratio is 45.02, net margin is 22.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 300653

Market cap
$3.48B
P/E ratio
45.02
Gross profit (TTM)
$296.28M
Net margin
22.2%

Yantai Zhenghai Bio-Tech Co Ltd (300653) — FAQ

What is Yantai Zhenghai Bio-Tech Co Ltd's market cap?

Yantai Zhenghai Bio-Tech Co Ltd (300653) has a reported market cap of $3.48B (data as of 2026-03-28).

What is 300653's P/E ratio?

The price-to-earnings (P/E) ratio for Yantai Zhenghai Bio-Tech Co Ltd (300653) is 45.02 (data as of 2026-03-28).

Does Yantai Zhenghai Bio-Tech Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Yantai Zhenghai Bio-Tech Co Ltd (300653). Check the MyAverix Finance app for the latest dividend data.

What sector is Yantai Zhenghai Bio-Tech Co Ltd in?

Yantai Zhenghai Bio-Tech Co Ltd (300653) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 300653 listed on?

300653 is listed on SHE.

What is Yantai Zhenghai Bio-Tech Co Ltd's net margin?

Yantai Zhenghai Bio-Tech Co Ltd (300653) reports a net margin of 22.2% (data as of 2026-03-28).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play